These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 29197745)

  • 1. Cancer chemoprevention revisited: Cytochrome P450 family 1B1 as a target in the tumor and the microenvironment.
    D'Uva G; Baci D; Albini A; Noonan DM
    Cancer Treat Rev; 2018 Feb; 63():1-18. PubMed ID: 29197745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Activation of Procarcinogens by CYP1A1/1B1 and Related Chemo-Preventive Agents: A Review.
    Li Y; Cui J; Jia J
    Curr Cancer Drug Targets; 2021; 21(1):21-54. PubMed ID: 33023449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450 1 family and cancers.
    Go RE; Hwang KA; Choi KC
    J Steroid Biochem Mol Biol; 2015 Mar; 147():24-30. PubMed ID: 25448748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP1B1: A Promising Target in Cancer Drug Discovery.
    Fabris M; Luiza Silva M; de Santiago-Silva KM; de Lima Ferreira Bispo M; Goes Camargo P
    Anticancer Agents Med Chem; 2023; 23(9):981-988. PubMed ID: 36655529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tangeretin inhibits the proliferation of human breast cancer cells via CYP1A1/CYP1B1 enzyme induction and CYP1A1/CYP1B1-mediated metabolism to the product 4' hydroxy tangeretin.
    Surichan S; Arroo RR; Tsatsakis AM; Androutsopoulos VP
    Toxicol In Vitro; 2018 Aug; 50():274-284. PubMed ID: 29626627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P450 CYP1 metabolism of hydroxylated flavones and flavonols: Selective bioactivation of luteolin in breast cancer cells.
    Wilsher NE; Arroo RR; Matsoukas MT; Tsatsakis AM; Spandidos DA; Androutsopoulos VP
    Food Chem Toxicol; 2017 Dec; 110():383-394. PubMed ID: 29097115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of cytochrome P450 1B1 inhibitors as new promising anti-cancer agents.
    Chun YJ; Kim S
    Med Res Rev; 2003 Nov; 23(6):657-68. PubMed ID: 12939788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Synthesis of Chalcones as Anticancer Prodrugs and their Bioactivation in CYP1 Expressing Breast Cancer Cells.
    Ruparelia KC; Zeka K; Ijaz T; Ankrett DN; Wilsher NE; Butler PC; Tan HL; Lodhi S; Bhambra AS; Potter GA; Arroo RRJ; Beresford KJM
    Med Chem; 2018; 14(4):322-332. PubMed ID: 29332599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycyrrhiza glabra extract and quercetin reverses cisplatin resistance in triple-negative MDA-MB-468 breast cancer cells via inhibition of cytochrome P450 1B1 enzyme.
    Sharma R; Gatchie L; Williams IS; Jain SK; Vishwakarma RA; Chaudhuri B; Bharate SB
    Bioorg Med Chem Lett; 2017 Dec; 27(24):5400-5403. PubMed ID: 29150398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and Synthesis of New α-Naphthoflavones as Cytochrome P450 (CYP) 1B1 Inhibitors To Overcome Docetaxel-Resistance Associated with CYP1B1 Overexpression.
    Cui J; Meng Q; Zhang X; Cui Q; Zhou W; Li S
    J Med Chem; 2015 Apr; 58(8):3534-47. PubMed ID: 25799264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Oxidation on Berberine-Mediated CYP1 Inhibition: Oxidation Behavior and Metabolite-Mediated Inhibition.
    Lo SN; Shen CC; Chang CY; Tsai KC; Huang CC; Wu TS; Ueng YF
    Drug Metab Dispos; 2015 Jul; 43(7):1100-7. PubMed ID: 25953522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinazoline derivatives as selective CYP1B1 inhibitors.
    Mohd Siddique MU; McCann GJ; Sonawane VR; Horley N; Gatchie L; Joshi P; Bharate SB; Jayaprakash V; Sinha BN; Chaudhuri B
    Eur J Med Chem; 2017 Apr; 130():320-327. PubMed ID: 28259840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids.
    Androutsopoulos VP; Papakyriakou A; Vourloumis D; Spandidos DA
    Bioorg Med Chem; 2011 May; 19(9):2842-9. PubMed ID: 21482471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of procarcinogen-bioactivating human CYP1A1, CYP1A2 and CYP1B1 enzymes by melatonin.
    Chang TK; Chen J; Yang G; Yeung EY
    J Pineal Res; 2010 Jan; 48(1):55-64. PubMed ID: 19919601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting drug-metabolizing enzymes for effective chemoprevention and chemotherapy.
    Swanson HI; Njar VC; Yu Z; Castro DJ; Gonzalez FJ; Williams DE; Huang Y; Kong AN; Doloff JC; Ma J; Waxman DJ; Scott EE
    Drug Metab Dispos; 2010 Apr; 38(4):539-44. PubMed ID: 20233842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of cancer-related genes - Cyp1a1, Cyp1b1, Cyp19, Nqo1 and Comt - expression in β-naphthoflavone-treated mice by miroestrol.
    Chatuphonprasert W; Jarukamjorn K; Putalun W
    J Pharm Pharmacol; 2016 Apr; 68(4):475-84. PubMed ID: 26893163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of human cytochrome P450 1B1 expression by 2,4,3',5'-tetramethoxystilbene.
    Chun YJ; Lee SK; Kim MY
    Drug Metab Dispos; 2005 Dec; 33(12):1771-6. PubMed ID: 16120791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine D2-Receptor Antagonists Down-Regulate CYP1A1/2 and CYP1B1 in the Rat Liver.
    Harkitis P; Daskalopoulos EP; Malliou F; Lang MA; Marselos M; Fotopoulos A; Albucharali G; Konstandi M
    PLoS One; 2015; 10(10):e0128708. PubMed ID: 26466350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, biological evaluation and docking studies of trans-stilbene methylthio derivatives as cytochromes P450 family 1 inhibitors.
    Wierzchowski M; Dutkiewicz Z; Gielara-Korzańska A; Korzański A; Teubert A; Teżyk A; Stefański T; Baer-Dubowska W; Mikstacka R
    Chem Biol Drug Des; 2017 Dec; 90(6):1226-1236. PubMed ID: 28632937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The synthesis of 4,6-diaryl-2-pyridones and their bioactivation in CYP1 expressing breast cancer cells.
    Ruparelia KC; Lodhi S; Ankrett DN; Wilsher NE; Arroo RRJ; Potter GA; Beresford KJM
    Bioorg Med Chem Lett; 2019 Jun; 29(11):1403-1406. PubMed ID: 30935796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.